Corvus Pharmaceuticals Inc (CRVS) — Working Capital to Net Assets Ratio
Corvus Pharmaceuticals Inc (CRVS) has a Working Capital to Net Assets ratio of 92.0% as of June 2026. Working capital of $207.29 Million (current assets of $220.97 Million minus current liabilities of $13.67 Million) is measured against net assets of $225.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Corvus Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Corvus Pharmaceuticals Inc Working Capital to Net Assets (2014–2025)
This chart shows how Corvus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 92.0%, reflecting working capital of $207.29 Million against net assets of $225.33 Million USD. For the complete balance sheet picture, see CRVS asset base.
Annual Working Capital to Net Assets for Corvus Pharmaceuticals Inc (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Corvus Pharmaceuticals Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Corvus Pharmaceuticals Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.8% | $48.83 Million | $61.20 Million | $58.21 Million | $9.38 Million | ▲ +21.4 pp |
| 2024 | 58.4% | $19.00 Million | $32.57 Million | $54.41 Million | $35.40 Million | ▲ +3.8 pp |
| 2023 | 54.5% | $21.09 Million | $38.68 Million | $27.96 Million | $6.87 Million | ▼ -4.1 pp |
| 2022 | 58.7% | $32.91 Million | $56.12 Million | $43.66 Million | $10.75 Million | ▼ -4.8 pp |
| 2021 | 63.4% | $61.62 Million | $97.16 Million | $71.31 Million | $9.69 Million | ▲ +17.4 pp |
| 2020 | 46.0% | $33.19 Million | $72.15 Million | $45.34 Million | $12.15 Million | ▼ -51.2 pp |
| 2019 | 97.2% | $69.12 Million | $71.11 Million | $79.34 Million | $10.22 Million | ▲ +0.5 pp |
| 2018 | 96.7% | $106.70 Million | $110.34 Million | $114.60 Million | $7.90 Million | ▲ +2.3 pp |
| 2017 | 94.4% | $80.11 Million | $84.83 Million | $90.06 Million | $9.94 Million | ▼ -1.6 pp |
| 2016 | 96.0% | $127.55 Million | $132.80 Million | $134.90 Million | $7.35 Million | ▲ +393.8 pp |
| 2015 | -297.7% | $92.59 Million | $-31.10 Million | $95.66 Million | $3.07 Million | ▲ +5900.4 pp |
| 2014 | -6198.1% | $9.86 Million | $-159.00K | $12.53 Million | $2.67 Million | — |